HealthEquity Reports First Quarter Ended April 30, 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
Jefferies Reiterates Buy Rating on HealthEquity, Inc (HQY)
June 3, 2024 4:33 PM EDTJefferies analyst Glen Santangelo reiterated a Buy rating and $95.00 price target on HealthEquity, Inc (NASDAQ: HQY)
The analyst comments "HQY reported another exceptional qtr with revs and EBITDA comfortably ahead. The company is executing well, benefitting from strong HSA sales, greater utilization of... More
